Application of statistical process control to qualitative molecular diagnostic assays.

by Cathal P O'brien, Cathal P O'brien, Stephen P Finn, Stephen P Finn
Published 2014-11-01

Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells

by Richard Heery, Stephen P. Finn, Sinead Cuffe, Steven G. Gray
Published 2017-04-01

Circular RNAs: Biogenesis, Function and Role in Human Diseases

by John Greene, John Greene, Anne-Marie Baird, Anne-Marie Baird, Anne-Marie Baird, Anne-Marie Baird, Lauren Brady, Marvin Lim, Steven G. Gray, Steven G. Gray, Steven G. Gray, Steven G. Gray, Raymond McDermott, Raymond McDermott, Stephen P. Finn, Stephen P. Finn, Stephen P. Finn, Stephen P. Finn
Published 2017-06-01

Diagnostic Strategies for Treatment Selection in Advanced Prostate Cancer

by Ciara S. McNevin, Anne-Marie Baird, Ray McDermott, Stephen P. Finn
Published 2021-02-01

Differential CircRNA Expression Signatures May Serve as Potential Novel Biomarkers in Prostate Cancer

by John Greene, John Greene, Anne-Marie Baird, Marvin Lim, Marvin Lim, Joshua Flynn, Ciara McNevin, Ciara McNevin, Lauren Brady, Orla Sheils, Orla Sheils, Steven G. Gray, Steven G. Gray, Raymond McDermott, Raymond McDermott, Stephen P. Finn, Stephen P. Finn, Stephen P. Finn
Published 2021-02-01

The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer

by Claire L. Tonry, Emma Leacy, Cinzia Raso, Stephen P. Finn, John Armstrong, Stephen R. Pennington
Published 2016-07-01

Carcinogenesis in prostate cancer: The role of long non-coding RNAs

by John Aird, Anne-Marie Baird, Marvin C.J. Lim, Ray McDermott, Stephen P. Finn, Steven G. Gray
Published 2018-03-01

Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small‐molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids

by Ezgi Oner, Mustafa Kotmakci, Anne-Marie Baird, Steven G. Gray, Bilge Debelec Butuner, Emir Bozkurt, Ayse Gulten Kantarci, Stephen P. Finn
Published 2021-03-01

RNAs as Candidate Diagnostic and Prognostic Markers of Prostate Cancer—From Cell Line Models to Liquid Biopsies

by Marvin C. J. Lim, Anne-Marie Baird, John Aird, John Greene, Dhruv Kapoor, Steven G. Gray, Ray McDermott, Stephen P. Finn
Published 2018-08-01

Deep Learning of Histopathological Features for the Prediction of Tumour Molecular Genetics

by Pierre Murchan, Cathal Ó’Brien, Shane O’Connell, Ciara S. McNevin, Anne-Marie Baird, Orla Sheils, Pilib Ó Broin, Stephen P. Finn
Published 2021-08-01

Exploitation of the vitamin A/retinoic acid axis depletes ALDH1-positive cancer stem cells and re-sensitises resistant non-small cell lung cancer cells to cisplatin

by Lauren MacDonagh, Rhyla Mae Santiago, Steven G. Gray, Eamon Breen, Sinead Cuffe, Stephen P. Finn, Kenneth J. O'Byrne, Martin P. Barr
Published 2021-04-01

Development and characterisation of a panel of phosphatidylinositide 3-kinase – mammalian target of rapamycin inhibitor resistant lung cancer cell lines

by Susan Heavey, Paul Dowling, Gillian Moore, Martin P. Barr, Niamh Kelly, Stephen G. Maher, Sinead Cuffe, Stephen P. Finn, Kenneth J. O’Byrne, Kathy Gately
Published 2018-01-01

Cost-Efficient and Easy to Perform PCR-Based Assay to Identify Met Exon 14 Skipping in Formalin-Fixed Paraffin-Embedded (FFPE) Non-Small Cell Lung Cancer (NSCLC) Samples

by Odharnaith O’Brien, Mark C. Wright, Cathal O’Brien, Orla Geoghegan, Niamh Leonard, Siobhan Nicholson, Sinéad Cuffe, Aurelie Fabre, Wolfram Jochum, Markus Joerger, Steven G. Gray, Stephen P. Finn
Published 2019-01-01

Prostate cancer-derived holoclones: a novel and effective model for evaluating cancer stemness

by Louise Flynn, Martin P. Barr, Anne-Marie Baird, Paul Smyth, Orla M. Casey, Gordon Blackshields, John Greene, Stephen R. Pennington, Emily Hams, Padraic G. Fallon, John O’Leary, Orla Sheils, Stephen P. Finn
Published 2020-07-01

Radium-223 in combination with enzalutamide in metastatic castration-resistant prostate cancer: a multi-centre, phase II open-label study

by Raymond S. McDermott, John Greene, John McCaffrey, Imelda Parker, Sylva Helanova, Anne-Marie Baird, Ausra Teiserskiene, Marvin Lim, Helen Matthews, Olwyn Deignan, John Feeney, Pierre G. Thirion, Stephen P. Finn, Paul J. Kelly
Published 2021-09-01

Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC

by Gillian Moore, Clara Lightner, Samira Elbai, Lauren Brady, Siobhan Nicholson, Ronan Ryan, Katie E. O’Sullivan, Kenneth J. O’Byrne, Carmen Blanco-Apiricio, Sinead Cuffe, Michael O’Neill, Susan Heavey, Stephen P. Finn, Kathy Gately
Published 2021-04-01

Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer

by Svitlana Tyekucheva, Michaela Bowden, Clyde Bango, Francesca Giunchi, Ying Huang, Chensheng Zhou, Arrigo Bondi, Rosina Lis, Mieke Van Hemelrijck, Ove Andrén, Sven-Olof Andersson, R. William Watson, Stephen Pennington, Stephen P. Finn, Neil E. Martin, Meir J. Stampfer, Giovanni Parmigiani, Kathryn L. Penney, Michelangelo Fiorentino, Lorelei A. Mucci, Massimo Loda
Published 2017-09-01